These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 7035118)
41. Aspirin and the risk of myocardial infarction. N Engl J Med; 1984 Jan; 310(2):122-3. PubMed ID: 6690919 [No Abstract] [Full Text] [Related]
42. Superior prevention of reinfarction by 30 mg/d aspirin compared with 1000 mg/d: results of a two years follow-up study in Cottbus. Förster W; Hoffmann W Biomed Biochim Acta; 1988; 47(10-11):S248-51. PubMed ID: 3073765 [TBL] [Abstract][Full Text] [Related]
43. [Role of antithrombotic agents after myocardial infarction]. Castaigne A; Albo C; Verschuren P; Perchet H; Pham I; Saal JP Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1703-8. PubMed ID: 1304143 [TBL] [Abstract][Full Text] [Related]
44. Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)? Olson J; Huntington J J Fam Pract; 2001 Jul; 50(7):623. PubMed ID: 11485713 [No Abstract] [Full Text] [Related]
45. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders]. Thiele R Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068 [No Abstract] [Full Text] [Related]
48. [Aftercare of heart infarct patients to reduce the risk of a subsequent infarction]. Offerhaus L Ned Tijdschr Geneeskd; 1983 Apr; 127(16):673-9. PubMed ID: 6134240 [No Abstract] [Full Text] [Related]
49. Antithrombotic agents in coronary artery disease. Resnekov L; Chediak J; Hirsh J; Lewis HD Chest; 1989 Feb; 95(2 Suppl):52S-72S. PubMed ID: 2644104 [No Abstract] [Full Text] [Related]
50. [Acetylsalicylic acid as antithrombotic agent in acute myocardial infarct without shock syndrome]. Thiele G; Fiedler H Z Gesamte Inn Med; 1973 Feb; 28(3):36-8 passim. PubMed ID: 4701331 [No Abstract] [Full Text] [Related]
51. Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome. van den Bergh PJ; Kievit PC; Brouwer MA; Aengevaeren WR; Veen G; Verheugt FW Am Heart J; 2009 Mar; 157(3):532-40. PubMed ID: 19249425 [TBL] [Abstract][Full Text] [Related]
52. Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patient. Smith DA Cardiology; 2008; 111(3):158-60. PubMed ID: 18434718 [No Abstract] [Full Text] [Related]
53. [State of the blood coagulation system in patients with myocardial infarct and chest pain and the changes in it during the use of anticoagulants and fibrinolysin]. Liusov VA Kardiologiia; 1967 Sep; 7(9):29-35. PubMed ID: 4238551 [No Abstract] [Full Text] [Related]
57. Aspirin or warfarin: what's best after a heart attack? Risk of bleeding counters warfarin's edge in efficacy. Ornato JP Health News; 2002 Nov; 8(11):3. PubMed ID: 12523247 [No Abstract] [Full Text] [Related]
58. [Fibrinolytic therapy in severe angina pectoris]. Benda L; Redtenbacher L; Spiess A; Steinbach T Dtsch Med Wochenschr; 1971 Apr; 96(18):771-7. PubMed ID: 4995698 [No Abstract] [Full Text] [Related]
59. [Lasting anticoagulant prevention following myocardial infarct]. Remde W Z Gesamte Inn Med; 1968 Mar; 23(6):85-8. PubMed ID: 5727299 [No Abstract] [Full Text] [Related]
60. Unstable angina: status of aspirin and other forms of therapy. Lewis HD Circulation; 1985 Dec; 72(6 Pt 2):V155-60. PubMed ID: 3905054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]